Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aralez Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 11
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Aralez Pharma Acquires US Rights to Toprol-XL and Authorized Generic from AstraZeneca 13
Aralez Pharma Acquires US and Canadian rights to Zontivity from Merck 15
Venture Financing 16
Aralez Pharma Secures USD75 Million in Venture Debt Financing 16
Private Equity 17
Aralez Pharma to Sell its Toprol XL Franchise 17
Partnerships 18
Lannett Enters into Distribution Agreement with Aralez Pharma 18
Biohit Enters Into Distribution Agreement With Medical Futures 19
Merger 20
Pozen and Tribute Pharma Merges 20
Licensing Agreements 21
Pozen Enters Into Licensing Agreement With Desitin Arzneimittel For MT 400 21
Equity Offering 22
Aralez Pharma Plans to Raise up to USD100 Million in Public Offering of Securities 22
Aralez Pharma Raises USD45 Million in Private Placement of Shares 23
Pozen Plans Public Offering of Shares for USD57.5 Million 25
Asset Transactions 26
Nuvo Pharma to Acquire Pharma Business from Aralez Pharma for USD110 Million 26
Acquisition 28
Tribute Pharma Acquires Medical Futures for USD20 Million 28
Aralez Pharmaceuticals Inc – Key Competitors 29
Aralez Pharmaceuticals Inc – Key Employees 30
Aralez Pharmaceuticals Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 33
Strategy And Business Planning 33
Aug 13, 2018: Aralez Pharmaceuticals divests core businesses for $250m 33
May 08, 2018: Aralez Announces New Strategic Direction 34
Financial Announcements 35
May 08, 2018: Aralez Announces First Quarter 2018 Financial Results 35
Mar 13, 2018: Aralez Announces Fourth Quarter and Full-Year 2017 Financial Results 37
Nov 09, 2017: Aralez Announces Third Quarter 2017 Financial Results 40
Aug 09, 2017: Aralez Reports Second Quarter 2017 Financial Results 42
May 09, 2017: Aralez Reports First Quarter 2017 Financial Results 44
Mar 13, 2017: Aralez Reports Fourth Quarter And Full-Year 2016 Financial Results 47
Corporate Communications 50
Nov 30, 2017: Aralez Announces Departure of Chief Financial Officer 50
Jun 07, 2017: Aralez Announces Board Member Resignation 51
Apr 05, 2017: Aralez Announces Reduction In U.S. Sales Force And Cost Savings Program 52
Legal and Regulatory 53
Aug 20, 2018: Nuvo Pharmaceuticals announces extension of exclusivity period with Aralez and Deerfield 53
Product News 54
02/16/2018: Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet by Company’s Subsidiary, Macoven Pharmaceuticals 54
02/03/2017: Pernix Therapeutics Provides Update on Arbitration 55
Product Approvals 56
Jan 09, 2017: Aralez Submits Marketing Authorization Application To The European Medicines Agency For PA10040 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aralez Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Aralez Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 11
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Aralez Pharma Acquires US Rights to Toprol-XL and Authorized Generic from AstraZeneca 13
Aralez Pharma Acquires US and Canadian rights to Zontivity from Merck 15
Aralez Pharma Secures USD75 Million in Venture Debt Financing 16
Aralez Pharma to Sell its Toprol XL Franchise 17
Lannett Enters into Distribution Agreement with Aralez Pharma 18
Biohit Enters Into Distribution Agreement With Medical Futures 19
Pozen and Tribute Pharma Merges 20
Pozen Enters Into Licensing Agreement With Desitin Arzneimittel For MT 400 21
Aralez Pharma Plans to Raise up to USD100 Million in Public Offering of Securities 22
Aralez Pharma Raises USD45 Million in Private Placement of Shares 23
Pozen Plans Public Offering of Shares for USD57.5 Million 25
Nuvo Pharma to Acquire Pharma Business from Aralez Pharma for USD110 Million 26
Tribute Pharma Acquires Medical Futures for USD20 Million 28
Aralez Pharmaceuticals Inc, Key Competitors 29
Aralez Pharmaceuticals Inc, Key Employees 30
Aralez Pharmaceuticals Inc, Other Locations 31
Aralez Pharmaceuticals Inc, Subsidiaries 31
List of Figures
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aralez Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 11
【免責事項】
http://www.globalresearch.jp/disclaimer